Monocyclic derivatives of aryl alkanoic acids and their use...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S314000, C544S327000

Reexamination Certificate

active

07348334

ABSTRACT:
The present invention relates to novel hypolipidemic, antihyperglycemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel β-aryl-α-oxysubstituted alkylcarboxylic acids of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them.

REFERENCES:
patent: 5518994 (1996-05-01), Kawamura et al.
patent: 5885997 (1999-03-01), Lohray et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Monocyclic derivatives of aryl alkanoic acids and their use... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monocyclic derivatives of aryl alkanoic acids and their use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monocyclic derivatives of aryl alkanoic acids and their use... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3978204

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.